Histamine enhances TGF-β1-mediated suppression of Th2 responses

FASEB Journal

Volumn 17, Issue 9, 2003, Pages 1089-1095

  Kunzmann, S ^a   Mantel, P Y ^a   Wohlfahrt, J G ^a   Akdis, M ^a   Blaser, K ^a   Schmidt Weber, C B ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

cAMP PKA pathway; CD4+ T cells; Nucleofection; Transforming growth factor 1

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ALLERGIC REACTION; ARTICLE; AUTOIMMUNITY; BLOOD VESSEL PERMEABILITY; COMPLEX FORMATION; CYTOKINE RELEASE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION; TH2 CELL; TISSUE SPECIFICITY;

ADENYLATE CYCLASE; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG SYNERGISM; HISTAMINE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0037709966     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-1008com     Document Type: Article

References (39)

1. Read, S., and Powrie, F. (2001) CD4(+) regulatory T cells. Curr. Opin. Immunol. 13, 644-649
2. Weiner, H. L. (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 182, 207-214
3. Akdis, C. A., and Blaser, K. (1999) IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J. 13, 603-609
4. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature (London) 390, 465-471
5. White, M. V. (1990) The role of histamine in allergic diseases. J. Allergy Clin. Immunol. 86, 599-605
6. Kay, A. B. (2001) Allergy and allergic diseases. Second of two parts. N. Engl. J. Med. 344, 109-113
7. Kay, A. B. (2001) Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344, 30-37
8. Bachert, C. (2002) The role of histamine in allergic disease: re-appraisal of its inflammatory potential. Allergy 57, 287-296
9. Hill, S. J. (1990) Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42, 45-83
10. Haaksma, E. E., Leurs, R., and Timmerman, H. (1990) Histamine receptors: subclasses and specific ligands. Pharmacol. Ther. 47, 73-104
11. Smit, M. J., Hoffmann, M., Timmerman, H., and Leurs, R. (1999) Molecular properties and signalling pathways of the histamine H1 receptor. Clin. Exp. Allergy 29, Suppl. 3, 19-28
12. Del Valle, J., and Gantz, I. (1997) Novel insights into histamine H2 receptor biology. Am. J. Physiol. 273, G987-G996
13. Drutel, G., Peitsaro, N., Karlstedt, K., Wieland, K., Smit, M. J., Timmerman, H., Panula, P., and Leurs, R. (2001) Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol. Pharmacol. 59, 1-8
14. Oda, T., Morikawa, N., Saito, Y., Masuho, Y., and Matsumoto, S. (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 275, 36781-36786
15. Zhu, Y., Michalovich, D., Wu, H., Tan, K. B., Dytko, G. M., Mannan, I. J., Boyce, R., Alston, J., Tierney, L. A., Li, X., et al. (2001) Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol. 59, 434-441
16. Schneider, E., Rolli-Derkinderen, M., Arock, M., and Dy, M. (2002) Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 23, 255-263
17. Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A., Malolepszy, J., Zak-Nejmark, T., Koga, R., Kobayashi, T., Blaser, K., et al. (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature (London) 413, 420-425
18. Jonk, L, J., Itoh, S., Heldin, C. H., ten Dijke, P., and Kruijer, W. (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273, 21145-21152
19. Akdis, M., Klunker, S., Schliz, M., Blaser, K., and Akdis, C. A. (2000) Expression of cutaneous lymphocyte-associated antigen on human CD4 (+) and CDS(+) Th2 cells. Eur. J. Immunol. 30, 3533-3541
20. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., and Enk, A. H. (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285-1294
21. Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B., and Fauci, A. S. (1986) Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163, 1037-1050
22. Ulloa, L., Doody, J., and Massague, J. (1999) Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature (London) 397, 710-713
23. Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., and Bottinger, E. P. (2000) A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 14, 187-197
24. Shaywitz, A. J., and Greenberg, M. E. (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68, 821-861
25. Rogge, L., Bianchi, E., Biffi, M., Bono, E., Chang, S. Y., Alexander, H., Santini, C., Ferrari, G., Sinigaglia, L., Seiler, M., et al. (2000) Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 25, 96-101
26. Schmidt-Weber, C. B., and Blaser, K. (2002) T-cell tolerance in allergic response. Allergy 57, 762-768
27. Schmidt-Weber, C. B., Kunzmann, S., and Blaser, K. (2002) TGF-beta-mediated control of allergen-specific T-cell responses. Curr. Allergy Asthma Rep. 2, 259-262
28. Vang, T., Torgersen, K. M., Sundvold, V., Saxena, M., Levy, F. O., Skalhegg, B. S., Hansson, V., Mustelin, T., and Tasken, K. (2001) Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193, 497-507
29. Poluektova, L. Y., Huggler, G. K., Patterson, E. B., and Khan, M. M. (1999) Involvement of protein kinase A in histamine-mediated inhibition of IL-2 mRNA expression in mouse splenocytes. Immunopharmacology 41, 77-87
30. Casale, T. B., Wood, D., Richerson, H. B., Trapp, S., Metzger, W. J., Zavala, D., and Hunninghake, G. W. (1987) Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J. Clin. Invest. 79, 1197-1203
31. Adams, G. K., III, and Lichtenstein, L. (1979) In vitro studies of antigen-induced bronchospasm: effect of antihistamine and SRS-A antagonist on response of sensitized guinea pig and human airways to antigen. J. Immunol. 122, 555-562
32. Zheng, T., Nathanson, M. H., and Elias, J. A. (1994) Histamine augments cytokine-stimulated IL-11 production by human lung fibroblasts. J. Immunol. 153, 4742-4752
33. Bourne, H. R., Lichtenstein, L. M., Melmon, K. L., Henney, C. S., Weinstein, Y., and Shearer, G. M. (1974) Modulation of inflammation and immunity by cyclic AMP. Science 184, 19-28
34. Kammer, G. M. (1988) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9, 222-229
35. Murray, A. W., Froscio, M., and Kemp, B. E. (1972) Histone phosphatase and cyclic nucleotide-stimulated protein kinase from human lymphocytes. Biochem. J. 129, 995-1002
36. Kemp, B. E., Froscio, M., Rogers, A., and Murray, A. W. (1975) Multiple protein kinases from human lymphocytes. Identification enzymes phosphorylating exogenous histon and casein. Biochem. J. 145, 241-249
37. Muller, U., Hari, Y., and Berchtold, E. (2001) Premedication with antihistamines may enhance efficacy of specific allergen immunotherapy. J. Allergy Clin. Immunol. 107, 81-86
38. Diepgen, T. L. (2002) Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr. Allergy Immunol. 13, 278-286
39. Gelfand, E. W., Cui, Z. H., Takeda, K., Kanehiro, A., and Joetham, A. (2002) Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J. Allergy Clin. Immunol. 110, 85-95